Please login to the form below

Not currently logged in
Email:
Password:

JMC Partners strengthens senior team

Appoints Andrew Bonser as director, policy andprojects

JMC Partners Andrew BonserLondon-based communications consultancy JMC Partners has appointed former Pfizer policy and government affairs director Andrew Bonser as director, policy and projects.

John Murray, managing director of JMC, said: “Andrew's arrival consolidates our position in the vanguard of healthcare policy. In particular, his knowledge of primary care will prove invaluable as the NHS and local government increasingly come together.”

Bonser was most recently director of public policy at Walgreens Boots Alliance, a role he had held since 2010 and which saw him hold public policy responsibilities across its retail and healthcare interests.

Prior that that Bonser served industry-side at Pfizer Global Pharmaceuticals as European government affairs director, having worked for the company as its director of European trade policy before that.

He said: “JMC has one of the most exciting client lists in healthcare and I look forward to bringing my expertise to bear in helping them achieve success at a time of great challenge and opportunity.”

24th September 2015

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....
The concordance conundrum: creating space for open dialogue
Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in...
Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...

Infographics